nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—AVPR2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0282	0.032	CbGpPWpGaD
Tolvaptan—AVPR1A—central nervous system—attention deficit hyperactivity disorder	0.0228	0.194	CbGeAlD
Tolvaptan—AVPR2—nervous system—attention deficit hyperactivity disorder	0.0196	0.167	CbGeAlD
Tolvaptan—AVPR2—central nervous system—attention deficit hyperactivity disorder	0.0189	0.16	CbGeAlD
Tolvaptan—AVPR1A—brain—attention deficit hyperactivity disorder	0.0181	0.154	CbGeAlD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0162	0.0183	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.016	0.0182	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0159	0.018	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0158	0.0179	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0157	0.0178	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0157	0.0178	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0156	0.0177	CbGpPWpGaD
Tolvaptan—AVPR2—brain—attention deficit hyperactivity disorder	0.015	0.127	CbGeAlD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0138	0.0157	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0137	0.0156	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0136	0.0154	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0135	0.0153	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0115	0.013	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.011	0.0124	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0109	0.0124	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0109	0.0123	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0105	0.012	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0105	0.0119	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0103	0.0117	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0103	0.0116	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00959	0.0109	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00952	0.0108	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0094	0.0107	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00933	0.0106	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00892	0.0101	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00888	0.0101	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00885	0.01	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00882	0.01	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00864	0.00979	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00857	0.00972	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00849	0.00962	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00843	0.00955	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00838	0.0095	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00832	0.00944	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00822	0.00932	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00816	0.00925	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00807	0.00914	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00801	0.00908	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00781	0.00885	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00775	0.00879	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00764	0.00866	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00758	0.0086	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0074	0.00839	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00735	0.00833	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00727	0.00824	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00722	0.00818	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00718	0.00814	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00716	0.00812	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00713	0.00808	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00711	0.00806	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00708	0.00802	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00669	0.00759	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00664	0.00753	CbGpPWpGaD
Tolvaptan—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00663	0.00751	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00633	0.00717	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00626	0.00709	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00621	0.00704	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00596	0.00675	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00591	0.00671	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00584	0.00662	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00582	0.00659	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00579	0.00657	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00578	0.00655	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00563	0.00639	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00559	0.00634	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00554	0.00628	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0055	0.00623	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00547	0.0062	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00547	0.0062	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00543	0.00616	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00543	0.00616	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00541	0.00613	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00537	0.00609	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0053	0.00601	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00526	0.00597	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0051	0.00578	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00506	0.00573	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00476	0.0054	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00473	0.00536	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00469	0.00531	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00465	0.00527	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00405	0.00459	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00402	0.00455	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00398	0.00452	CbGpPWpGaD
Tolvaptan—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0039	0.0331	CbGeAlD
Tolvaptan—AVPR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00372	0.00422	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00369	0.00419	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00367	0.00416	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00365	0.00413	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00357	0.00405	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00354	0.00402	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00354	0.00401	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00351	0.00398	CbGpPWpGaD
Tolvaptan—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.0033	0.028	CbGeAlD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00329	0.00373	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00326	0.0037	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00321	0.00364	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0032	0.00362	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00319	0.00361	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00318	0.00361	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00317	0.0036	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00316	0.00358	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00313	0.00355	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00313	0.00355	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00311	0.00352	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00311	0.00352	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00309	0.0035	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00307	0.00348	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00307	0.00348	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00305	0.00346	CbGpPWpGaD
Tolvaptan—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00299	0.0254	CbGeAlD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00299	0.00338	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00296	0.00336	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00289	0.00328	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00288	0.00326	CbGpPWpGaD
Tolvaptan—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00288	0.0244	CbGeAlD
Tolvaptan—AVPR2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00287	0.00325	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00286	0.00324	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00284	0.00322	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00282	0.0032	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00281	0.00318	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00279	0.00316	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00261	0.00296	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0026	0.00294	CbGpPWpGaD
Tolvaptan—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00257	0.0218	CbGeAlD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00218	0.00247	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00217	0.00246	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00215	0.00244	CbGpPWpGaD
Tolvaptan—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00212	0.018	CbGeAlD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00208	0.00236	CbGpPWpGaD
Tolvaptan—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00204	0.0173	CbGeAlD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00204	0.00231	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00202	0.00229	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.002	0.00227	CbGpPWpGaD
Tolvaptan—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00199	0.0169	CbGeAlD
Tolvaptan—AVPR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.0019	0.00215	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00188	0.00214	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00183	0.00208	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00182	0.00206	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00176	0.002	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00175	0.00198	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00171	0.00194	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0017	0.00192	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00168	0.0019	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00167	0.00189	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00166	0.00188	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00165	0.00187	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00163	0.00185	CbGpPWpGaD
Tolvaptan—ABCB1—brain—attention deficit hyperactivity disorder	0.00162	0.0137	CbGeAlD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00156	0.00177	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00154	0.00175	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00153	0.00174	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00109	0.00123	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00108	0.00123	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00108	0.00123	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00107	0.00122	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00107	0.00122	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000759	0.00086	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000723	0.000819	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000697	0.00079	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000573	0.00065	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000569	0.000645	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000499	0.000566	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000499	0.000566	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000491	0.000556	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000456	0.000517	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000445	0.000505	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000399	0.000452	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00038	0.00043	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000307	0.000348	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000307	0.000348	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000302	0.000343	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000302	0.000343	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.0003	0.00034	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000281	0.000319	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000246	0.000279	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000234	0.000265	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000186	0.000211	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000185	0.00021	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.00013	0.000147	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	7.99e-05	9.05e-05	CbGpPWpGaD
